Document is current
Any future updates will be listed below
-
Authors
Yan, Lei https://orcid.org/0000-0003-1775-5533
Wang, Fulian
Hill, Michelle
Brun, Juliane
Liang, Ze
Shi, Xinyu
Zhang, Liangminghui
He, Xiuxiu
Li, Yu
Huang, Qianping
Dong, Xuxue
Liu, Huanzhen
Zhang, Yi
Liu, Lili
Dwek, Raymond A. https://orcid.org/0000-0001-9989-2245
Zitzmann, Nicole https://orcid.org/0000-0003-1969-4949
Liang, Aibin https://orcid.org/0000-0002-8978-1987
Yang, Guang https://orcid.org/0000-0001-7379-6810
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology of the People's Republic of China (2021YFA1100800)
Jiangsu Science and Technology Department (BK20233003)
Oxford Glycobiology Endowment and the University of Oxford's COVID-19 Research Response Fund
- License Information
-
More Information
Article History
Received: 30 January 2025
Accepted: 6 August 2025
First Online: 15 August 2025
Competing interests
: G.Y. and L.Y. are inventors on a patent application describing the cross-reactive antibody 3D1 (Case No. P240115226CN, Application No. 2025105093316). The other authors declare that they have no competing interests.
